Zacks Investment Research upgraded shares of Senseonics Holdings Inc (NASDAQ:SENS) from a sell rating to a hold rating in a research note published on Thursday.
According to Zacks, “Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. “
Shares of Senseonics Holdings (NASDAQ:SENS) opened at 2.86 on Thursday. The firm’s market cap is $267.10 million. The company has a 50 day moving average of $2.72 and a 200 day moving average of $3.49. Senseonics Holdings has a 1-year low of $2.17 and a 1-year high of $4.24.
Senseonics Holdings Company Profile
Senseonics Holdings, Inc, formerly ASN Technologies, Inc, is a medical technology company. The Company is focused on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed to be an implantable CGM system to continually measure glucose levels in people with diabetes for a period of approximately 90 days.